Literature DB >> 27661667

Effect of Long Noncoding RNA H19 Overexpression on Intestinal Barrier Function and Its Potential Role in the Pathogenesis of Ulcerative Colitis.

Shan-Wen Chen1, Peng-Yuan Wang, Yu-Cun Liu, Lie Sun, Jing Zhu, Shuai Zuo, Ju Ma, Teng-Yu Li, Jun-Ling Zhang, Guo-Wei Chen, Xin Wang, Qiu-Ru Zhu, You-Wen Zheng, Ze-Yang Chen, Zi-Hao Yao, Yi-Sheng Pan.   

Abstract

BACKGROUND: Recently, long noncoding RNA (lncRNA) H19 has been reported to be related with VDR signaling and the development of inflammatory diseases including osteoarthritis. The aim of this study was to investigate the correlation between the expression level of H19 and VDR in ulcerative colitis (UC) tissues and to investigate the effect of H19 overexpression on intestinal epithelial barrier function.
METHODS: The expression level of H19, miR-675-5p, and VDR in UC tissues and paired normal tissues collected from 12 patients with UC was investigated by quantitative real-time polymerase chain reaction. Caco-2 monolayers were used to test the effect of H19 and miR-675-5p overexpression on the intestinal epithelial barrier function and the status of tight junction proteins and VDR. Luciferase assay was used to validate the target site of miR-675-5p in the 3'UTR of VDR mRNA.
RESULTS: The expression of H19 was found to be negatively correlated with the expression of VDR in UC tissues (r = 0.5369, P < 0.05). The expression of miR-675-5p was also found to be negatively correlated with the expression of VDR in UC tissues (r = 0.5233, P < 0.01). H19 overexpression increased Caco-2 monolayer permeability and decreased the expression of tight junction proteins and VDR, which was significantly attenuated by cotransfection with miR-675-5p inhibitors. The 3'UTR of VDR mRNA was validated to be one of the direct targets of miR-675-5p.
CONCLUSIONS: This study reveals the destructive effect of H19 overexpression on intestinal epithelial barrier function and suggests a potential role of H19 in the development of UC. In addition, H19 overexpression may be one of the mechanisms underlying the decreased expression of VDR in UC tissues and the interaction between H19 and VDR signaling may provide potential therapeutic targets for UC.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27661667     DOI: 10.1097/MIB.0000000000000932

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  23 in total

Review 1.  LncRNA: A Potential Research Direction in Intestinal Barrier Function.

Authors:  Zhi-Feng Jiang; Lin Zhang
Journal:  Dig Dis Sci       Date:  2020-06-26       Impact factor: 3.199

Review 2.  Emerging role of lncRNAs in the normal and diseased intestinal barrier.

Authors:  Jie Chen; Jianhua Wan; Jianfang Ye; Liang Xia; Nonghua Lu
Journal:  Inflamm Res       Date:  2018-07-14       Impact factor: 4.575

Review 3.  Long non-coding RNAs in immune regulation and their potential as therapeutic targets.

Authors:  Dinesh Babu Uthaya Kumar; Adam Williams
Journal:  Int Immunopharmacol       Date:  2020-02-12       Impact factor: 4.932

4.  LncRNA TUG1 regulates the balance of HuR and miR-29b-3p and inhibits intestinal epithelial cell apoptosis in a mouse model of ulcerative colitis.

Authors:  Yuxi Tian; Ying Wang; Fujun Li; Junwen Yang; Yan Xu; Miao Ouyang
Journal:  Hum Cell       Date:  2020-10-12       Impact factor: 4.174

Review 5.  Regulation of Human Breast Cancer by the Long Non-Coding RNA H19.

Authors:  Jordan Collette; Xuefen Le Bourhis; Eric Adriaenssens
Journal:  Int J Mol Sci       Date:  2017-11-03       Impact factor: 5.923

6.  lncRNA H19 is involved in TGF-β1-induced epithelial to mesenchymal transition in bovine epithelial cells through PI3K/AKT Signaling Pathway.

Authors:  Wei Yang; Xuezhong Li; Shaopei Qi; Xueru Li; Kun Zhou; Suzhu Qing; Yong Zhang; Ming-Qing Gao
Journal:  PeerJ       Date:  2017-10-17       Impact factor: 2.984

Review 7.  The emerging role of lncRNAs in inflammatory bowel disease.

Authors:  Reza Yarani; Aashiq H Mirza; Simranjeet Kaur; Flemming Pociot
Journal:  Exp Mol Med       Date:  2018-12-06       Impact factor: 8.718

Review 8.  The Good, the Bad, the Question-H19 in Hepatocellular Carcinoma.

Authors:  Lysann Tietze; Sonja M Kessler
Journal:  Cancers (Basel)       Date:  2020-05-16       Impact factor: 6.639

9.  LncRNA NEAT1 mediates intestinal inflammation by regulating TNFRSF1B.

Authors:  Shiyu Pan; Rui Liu; Xing Wu; Kejia Ma; Weiwei Luo; Kai Nie; Chao Zhang; Xiangrui Meng; Ting Tong; Xuejie Chen; Xiaoyan Wang; Minzi Deng
Journal:  Ann Transl Med       Date:  2021-05

Review 10.  Which long noncoding RNAs and circular RNAs contribute to inflammatory bowel disease?

Authors:  Lihui Lin; Gaoshi Zhou; Peng Chen; Ying Wang; Jing Han; Minhu Chen; Yao He; Shenghong Zhang
Journal:  Cell Death Dis       Date:  2020-06-15       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.